Primary Navigation for the CDC Website
CDC en Español

 

Avian Influenza A Virus Infections of Humans

Although avian influenza A viruses usually do not infect humans, rare cases of human infection with avian influenza A viruses have been reported. Most human infections with avian influenza A viruses have occurred following direct contact with infected poultry. Human clinical illness from infection with avian influenza A viruses has ranged from eye infections (conjunctivitis) to severe respiratory disease (pneumonia) to death.

Since November 2003, nearly 400 cases of human infection with highly pathogenic avian influenza A (H5N1) viruses have been reported by more than a dozen countries in Asia, Africa, the Pacific, Europe and the Near East. Highly pathogenic avian influenza A (H5N1) viruses have never been detected among wild birds, domestic poultry, or people in the United States. The World Health Organization (WHO) maintains situation updates and cumulative reports of human cases of avian influenza A (H5N1). Most human cases of H5N1 virus infection are thought to have occurred as a result of direct contact with sick or dead infected poultry.

Other subtypes of avian influenza A viruses also have infected humans, including low pathogenic and highly pathogenic virus strains. (For more information, see “Low Pathogenic versus Highly Pathogenic Avian Influenza Viruses” on the CDC Influenza Viruses Web page.) Public health authorities closely monitor outbreaks of human illness associated with avian influenza because of concerns about the potential for more widespread infection in the human population. The spread of avian influenza A viruses from one ill person to another has been reported very rarely, and has been limited, inefficient and unsustained. However, because avian influenza A viruses have the potential to change and gain the ability to spread easily between people, monitoring for human infection and person-to-person transmission is important. (See Information about Influenza Pandemics for more information.)

Instances of Avian Influenza A Virus Infections in Poultry

Avian influenza outbreaks among poultry occur worldwide from time to time. Since 1997, for example, and based on the World Organization for Animal Health (OIE) reporting criteria for Notifiable Avian Influenza in commercial poultry, the United States has experienced 17 incidents of H5 and H7 low pathogenic avian influenza (LPAI), and one incident of highly pathogenic avian influenza (HPAI) that was restricted to one poultry farm. The U.S. Department of Agriculture monitored and responded to these incidents.

In 2004, the United States experienced the first highly pathogenic avian influenza outbreak among poultry in 20 years. This was an outbreak of avian influenza A (H5N2) which occurred in Texas. The outbreak was reported in a flock of 7,000 chickens in south-central Texas. There was no report of transmission to humans.

For more information on reportable poultry outbreaks of avian influenza, visit the World Organization for Animal Health (OIE).

Instances of Avian Influenza A Virus Infections of Humans

Confirmed instances of avian influenza A virus infections of humans since 1996 include:

The World Health Organization (WHO) website provides a timeline of major avian influenza A (H5N1) events.

Signs and symptoms of Avian Influenza in Humans

The reported signs and  symptoms of avian influenza in humans have ranged from eye infections (conjunctivitis) to influenza-like illness symptoms (e.g., fever, cough, sore throat, muscle aches) to severe respiratory illness (e.g. pneumonia, acute respiratory distress, viral pneumonia) sometimes accompanied by nausea, diarrhea, vomiting and neurologic changes.

Antiviral Agents for Avian Influenza A Virus Infections of Humans

CDC and WHO recommend oseltamivir, a prescription antiviral medication, for treatment and prevention of human infection with avian influenza A viruses. Analyses of available H5N1 viruses circulating worldwide suggest that most viruses are susceptible to oseltamivir. However, some evidence of resistance to oseltamivir has been reported in H5N1 viruses isolated from some human H5N1 cases. Monitoring for antiviral resistance among avian influenza A viruses is important and ongoing.

Prevention of Avian Influenza A Virus Infections of Humans

Persons who work with poultry or respond to avian influenza outbreaks among poultry and are therefore potentially exposed to infected or potentially infected poultry are advised to follow recommended biosecurity and infection control practices including careful attention to hand hygiene, and to use appropriate personal protective equipment. In addition, HPAI poultry outbreak responders should adhere to guidance from CDC and WHO and receive seasonal influenza vaccination and take prophylactic antiviral medication during an outbreak control response. Responders to LPAI outbreaks should consider this guidance as part of their response plan. Seasonal influenza vaccination will not prevent infection with avian influenza A viruses. Exposed persons should be carefully monitored for symptoms that develop during and in 7 days after their last exposure to infected poultry or to environments potentially contaminated with avian influenza A virus-excretions/secretions.

Additional Information

http://www.who.int/medicines/publications/WHO_PSM_PAR_2006.6.pdf

http://www.cdc.gov/flu/avian/professional/protect-guid.htm

http://www.osha.gov/dts/shib/shib121304.html

http://www.osha.gov/Publications/3323-10N-2006-English-07-17-2007.html

Page last modified May 23, 2008

Navigation for the CDC Avian Flu Website

• Influenza (Flu)


Additional Navigation for the CDC Website

“Safer Healthier People”Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A.
800–CDC–INFO (800-232-4636), 888–232–6348 (TTY), cdcinfo@cdc.gov